Dialysis fluid may hold key to detecting dangerous scarring early
NCT ID NCT07208513
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at fluid from peritoneal dialysis to find biological markers that could signal peritoneal fibrosis, a common complication. Researchers will analyze genetic material and metabolites from 55 participants, including dialysis patients and healthy controls. The goal is to develop a way to detect fibrosis earlier, potentially improving patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple test to detect peritoneal fibrosis early in dialysis patients, helping doctors adjust treatment sooner.
What could go wrong
This is an early observational study with only 55 participants, so findings may not apply to all patients. It aims to find clues, not prove a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Renji Hospital
Shanghai, Shanghai Municipality, China